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                                 ABBREVATIONS 
 CA 19.9 –Carbohydrate Antigen 
CT – Computerised Topography 
Cath – Cathepsin 
5 –FU- 5- Fluorouracil 
 HPC- Human Pancreatic cells 
IPMN- Intraductal Papillary Mucinous Neoplasm 
LFT- Liver Function Test 
Mac 2 BP- Macrophage 2 Binding Protein 
MAP- Mitogen Activated Pathway  
MD- Moderately Differentiated 
MUC- Mucin 
MVD- Micro vessel Density  
NIR – Near Infra red fluorescence 
Pan IN- Pancreatic Intraepithelial Neoplasm 
PCR- Polymerase Chain Reaction 
PD- Poorly Differentiated 
Ro – no residual tumor 
 WD- Well Differentiated 
VEGF- Vascular Endothelial Growth Factor 
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                                    INTRODUCTION 
 
One of the leading causes of mortality in case of  malignancies is                                            
carcinoma of the pancreas.  Worldwide, in death due to malignancies , 
adenocarcinoma of the pancreas , has the  overall five year survival rate 
of 3% . 
 In India, the  pancreatic cancer  incidence is 1 to 2.5 / 1 lakh men. 
In the  United states it is the fifth leading cause of death.  
 
Most of the cases presents in advanced stage because of subtle 
clinical manifestation.  The percentage of those patients presenting with 
a resectable tumor is only 13 -22 % [1] .  With a curative resection the 
five year survival rate reaches to 25-30%. [2,3,4 ]. 
 
The causes for the poor prognosis of the tumor is attributed to: 
• Subtle clinical presentation. 
• Invasion of the adjacent blood vessels-Hematogenous metastasis  [5] 
• Neovascularization [6 ]  
• High Micro Vessel Density (MVD) of the tumor [7]  
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• Angiogenesis promoting factor – Vascular Epidermal Growth Factor 
(VEGF) [8] 
 
Besides angiogenesis, the local invasion of the tumor cells 
through detachment from the primary lesion is another important critical 
step in tumor progression  and metastasis. Local tumor invasion and 
metastasis  is also caused by the family of lysosomal cysteine proteases 
namely the Cathepsins. These proteases  plays critical role in distinct 
tumorigenic processes such as proliferation, angiogenesis, apoptosis and 
invasion into adjacent organs  and metastasis . They degrade the 
extracellular matrix and give neovascularization and tumor cell 
migration space [ 9,10,11 ] 
 
In case of solid tumors  , local tumor invasion has been promoted 
by  lysosomal proteases cathepsin   enzymes.  Of which highly 
expressed  Cathepsin  plays critical  role in  invasion and metastases of 
pancreatic   adenocarcinoma [12 ]. 
 
In a multi variate analysis, curative resection i.e no residual tumor 
(Ro) was the only clinical parameter related to favourable prognosis. 
Some cases have poor outcome despite curative resection [13] . In recent 
years, the expression of various factors like MVD, VEGF and cathepsins 
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were assessed using biological markers in terms of prognostic evaluation 
in pancreatic adenocarcinoma. Studies have shown that after curative 
resection numerous predictor factors  UICC stage, ,  tumor grading  and 
TNM classification  for survival , but cathepsin is believed to be 
essential predictor for early tumor  recurrence [14,15]. When compared 
to other organ tumors , pancreatic cancer has poor prognosis.   
When  all stages are  combined together : 
• 5-year relative survival rates is approximately  6%. 
• 1 year survival rate is 22 – 26 %. 
 The 5-year survival rate  is approximately 20% for local disease [16] . 
          In terms of months,  the median survival rate: 
• For locally advanced disease is 10 -12 months 
• For metastatic disease, it  is  about 6 - 8months respectively [17,18]. 
 
 This study focuses at assessing the correlation between the lysosomal 
proteases cathepsin D and pancreatic adenocarcinoma grade, perineural 
and lymphovascular invasion , serum Carbohydrate antigen 19.9 level in 
terms of prognosis. And thereby studying the histopathology of lesions 
with a note on incidence of the tumor during the study period.  
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                       AIMS AND OBJECTIVES 
 
Primary Objective: 
• To assess the diagnosis of pancreatic lesions by conventional 
histopathology technique . 
• To assess the positivity of cathepsin D and its correlation with nuclear 
grade, perineural invasion, lymphovascular invasion and serum 
carbohydrate antigen 19.9 levels.  
 
Secondary Objective: 
• To study the clinicopathological correlation in pancreatic carcinoma . 
• To find the incidence of pancreatic carcinoma during the study period. 
• To analyse pancreatic carcinoma with respect to age and sex of patients. 
• To analyse the correlation between alcoholism   and pancreatic carcinoma 
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                                      REVIEW OF LITERATURE 
  Pancreas adenocarcinoma  is fifth  cause of cancer related  death .  
In the global scale ,  Pancreatic carcinoma accounts for eighth cause of 
cancer-related deaths. fourth In the United states it is the fifth leading 
cause of death. [16].  
The incidence of pancreatic cancer in India is 1 to 2.5 / 1 lakh men . 
The 5-yr overall survival rate is only 3% [17]. 
 
Pancreatic carcinoma  originates from the transformed cells arising in 
pancreatic tissues.   Adenocarcinoma  accounts for 95% of the pancreatic  
tumors , which arise from  the pancreatic exocrine component.  
Neuroendocrine tumors , which constitutes  minority  of pancreatic 
tumor , arise from islet cells . 
   Diagnosis depends on the location,  size,  and  clinical features  and 
the  histopathological type of the tumor.  
 
Early pancreatic cancer do not cause  any clinical  symptoms. Advanced 
carcinoma shows non specific  symptoms. This results in  pancreatic 
cancer  diagnosing at an  advanced stage [17].  
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The word pancreas was derived from the Greek word , means  all flesh . 
It is a long, J-shaped organ measuring 10-16 cm in length , 2 -4 cm 
broad and 1-2 cm thick, weighing 70- 90 gms . It is a soft, lobulated 
organ located  retroperitoneally . 
 In the posterior abdominal wall , it lies transversely, lying  behind the 
stomach, across the lumbar  spine from L1 to L2 [19,20]. 
  
EMBROLOGY 
The development of pancreas  is by two endodermal outpouchings.It 
arises at the midline of the foregut and midgut ,  from the primitive 
duodenum ,as smaller ventral bud and larger dorsal bud .Both soon fuses 
to form the pancreas. 
  Small ventral bud gives rise to  the head . Large dorsal bud gives origin 
to  the body and uncinate process and tail of pancreas .  
The main  pancreatic duct  of Wirsung develops as a result of fusion of 
distal part of dorsal bud with entire  ventral bud.  Ventral bud also gives 
rise to common bile duct  and ultimately  common channel  is produced 
after fusion with the  duct of wirsung .  Rest  of the dorsal bud duct 
gives rise to accessory pancreatic duct of Santorini . At the site of 
duodenal major papillae , bile duct and the main pancreatic duct enters . 
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Islets of langerhans develops in the third month from the pancreatic 
tissue  [19]. 
 
Molecular Regulation of Pancreas 
Pancreatic and duodenal homeobox gene is upregulated .  Notochord 
synthesis Fibroblast growth factor 2 and activin , which helps in the 
development of pancreatic bud. 
 
Gross Anatomy 
Shape of the pancreas is prismoid . It  has three surfaces -anterosuperior,  
posterior,  and anteroinferior surfaces. It also has three borders-
superior,anterior and  inferior. 
Pancreas lies transversely at the level of first and second lumbar 
vertebrae. 
Grossly , it is divided into head, neck , body and tail . 
Head of pancreas – lies within curve of duodenum. It has :  
• Three borders - superior , right lateral and inferior border 
• Two surfaces – anterior and posterior 
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Uncinate process – related to aorta posteriorly and superior mesenteric 
vessels anteriorly. 
Neck of the pancreas- is a constricted part  , that  is present between 
head and body. Two surfaces present – anterior and posterior. 
Body –is elongated part , extending from neck to tail. It has : 
• Three borders – superior , anterior and inferior 
• Three surfaces – anterior , inferior and posterior 
Tail of pancreas – narrow left out end, lies in contact with lower portion 
of spleen. 
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             Endoscopic anatomy of pancreas 
The  pancreatic duct of Wirsung  runs  throughout the pancreas , and 
ultimately enters into the head in its  inferior part  . Common bile duct 
lower part and  uncinate process duct,  joins with wirsung duct in the 
inferior part of the  head.  
Ultimately results in the development of  hepatopancreatic ampulla, a 
common channel . It opens into the dome of the major duodenal papilla , 
after  running through the medial duodenal wall  . 
 Sphincter of Oddi , smooth muscle that  is present around  the common 
bile duct and  the pancreatic duct helps in preventing refluxion of 
duodenal juices.  
Refluxion of  bile into main pancreatic duct is prevented   by another 
muscle sphincter that  is present around its terminal part . 
Refluxion  of pancreatic juices into the common bile duct is prevented 
by another  smooth muscle  sphincter ,  that  surrounds  the common bile 
duct in its lower part. 
Drainage  of the head of the pancreas is done by accessory pancreatic 
duct, which  at the level of minor duodenal papilla  opens into the 
duodenum . 
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 Communication between  accessory pancreatic ducts and main duct  
occurs [19,20]. 
Relationship of pancreatic duct 
 
                                            
 
Endoscopic ultrasound anatomy 
 Endoscopic ultrasonography is the technical tool  that is developed 
recently to evaluate the pancreas . An ultrasonographic probe was 
mounted on endoscope , which is then  passed into duodenal C loop,   
the second part . 
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  By using it well visualized portions are the  head of pancreas , common 
bile duct- intrapancreatic part ,  both main and accessory ducts terminal 
parts, and pancreaticoduodenal lymph nodes. 
Nerve supply 
Thoracic splanchnic nerves and the celiac plexus gives origin to 
sympathetic supply . 
Via  celiac branch ,  posterior vagal trunk gives rise to parasympathetic 
nerve supply . 
Arterial supply 
At the level of T12 –L 1,  from the aorta , in its  anterior surface , celiac 
axis arises , which  divides  into splenic artery,  hepatic artery and 
pancretico duodenal arteries and left gastric artery . 
Splenic artery , by giving rise to multiple pancreatic branches  , supplies  
body and tail  . 
Venous Drainage 
Pancreato duodenal veins -  superior and inferior ,  are accompanied by 
the respective arteries. The portal vein drains the superior 
pancreaticoduodenal veins and the superior mesenteric vein drains the 
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inferior pancreaticoduodenal veins. Gastrocolic trunk receives venous 
drainage from the pancreatic  head . 
 From the  body and tail ,  numerous small veins , drains  directly into  
the splenic vein. 
Lymphatic drainage 
Pancreaticoduodenal and hepatoduodenal ligament  lymph nodes -  
drains  head of the pancreas  . 
 Superior mesenteric  and para aortic  nodes - drains body and tail  . 
Functions 
 Digestive -  by secretions of enzymes such as trypsin , lipase and amylase 
from pancreatic juice. 
 Endocrine – secretion of insulin and other hormones 
 Pancreatic juice – provides alkaline pH for other enzymes to perform its 
function. 
Histology 
Both exocrine and endocrine components  are present in this  lobulated 
gland . Exocrine pancreas constitutes most of the organ. It is separated 
by thin capsule which divides the pancreas into numerous lobules by 
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thin fibrous septae. Serous  acini, composed of zymogenic cells around 
central lumen ,  are arranged in lobules. 
 Islets of langerhans are found within  serous acini masses. Each lobule 
has its own ductules.  Ductules from the acini drains into intralobular 
ducts, which further drains into interlobular ducts and finally drains into 
the  main pancreatic duct branches . 
Serous  zymogenic cells secrete a variety of enzymes such as trypsin , 
lipase and amylase that helps in  digestion of protein ,  fats  and 
carbohydrates . [21]. 
Alkalinity of the pancreatic juice was due to bicarbonate secretion by 
ductular cells 
Pancreatic islets of  Langerhans – contains alpha cells ,  beta cells and 
delta cells that  secretes glucagon ,  insulin,  and  somatostatin. 
  Risk factors for pancreatic cancer may include: 
• Age-  pancreatic cancer  development increases with age. Rises to peak  
after  60 years, but  before 40 years are rare. 
• Smoking 
• Alcoholism 
• History of familial pancreatitis.  
• Low  fibre diet 
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• Obesity 
• Red meat  high diet 
• Diabetes mellitus  
• Soft drinks 
•  Pancreatitis – especially Chronic. 
• Helicobacter pylori infection  
• Family history  of pancreatic cancer – 5 -10% increased risk [17]. 
 
Genetic alterations associated with Pancreatic cancer : 
• Mutation in oncogenes – such as Her 2 neu , KRAS , MYB ,AKT 2 
• Tumor suppressor gene mutation –P 16 , P53, DPC 4 , BRCA 2 ,ALK 5 
and  LKB1 /STK11 
• DNA mismatch repair mutations – MSH 2, MLH 1[22,23]. 
 
Syndromes associated with Pancreatic cancer  are    : 
• Familial atypical multiple mole melanoma- cancer syndrome     
• Autosomal dominant- BRCA 2 gene mutation 
•  Peutz-Jeghers syndrome  
• Familial pancreatic cancer 
22 
 
•  Hereditary non-polyposis colon cancer 
• Ataxia Telangiectasia 
•  Familial adenomatous polyposis 
• Hereditary pancreatitis 
• Autosomal recessive ataxia-telangiectasia    [22,23]. 
 
Pathophysiology  
Acceleration  by genetic or environmental factors gives rise to 
pancreatic cancer development by: 
• Inactivation of tumor suppressor genes 
• Over expression of oncogenes. 
 
Precancerous lesion are: 
• Intraductal papillary mucinous neoplasms  
• Mucinous cystic neoplasms  
• Pancreatic intraepithelial neoplasia  
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Flow chart depicting pancreatic cancer  development : 
 
  
 
Clinical features 
Common symptoms include: 
• Upper abdominal pain  
• Nausea  
•  Vomiting 
• Anorexia 
• Weight loss   
• Jaundice.   
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• Itching – due to  excess bile  secretion 
• Trousseau sign- in which thrombosis occurs in the deep veins of the 
extremities and in the portal blood vessels . 
• New onset diabetes in an elderly individual  
• Symptoms of metastasis 
• Clinical depression  
 
Diagnosis: 
According to location of the cancer , clinical presentation varies : 
1. Malignancies in the pancreatic body and tail- causes  weight loss and 
pain 
2. Malignancies in head –causes jaundice and steatorrhea  . 
 
Laboratory diagnosis: 
Serum markers : 
• Liver function tests -raised conjugated bilirubin ,  alkaline 
phosphatase levels  and gamma glutamyl transpeptidase .  
• DUPAN 2 
• Carbohydrate antigen 19.9 level. 
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• SPAN 1 
• Carcino embryonic antigen 
 
Immunohistochemistry  
• Mucin 1,3 and 5/6 
• Cytokeratin 8 ,18 ,19 
• Carbohydrate antigen 19.9 
• DUPAN 2 
• CA 125 
• SPAN 1 
• Sialyl  SSEA 
• TAG 72 
 Imaging studies 
1. CT  scan-used for staging  
2. Endoscopic ultrasound  -latest technical tool to evaluate the pancreas 
3.Endoscopic Retrograde Cholangio Pancreatograpy 
3. Endoscopic needle biopsy or surgical excision -gives definitive 
diagnosis  .[44] 
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Most  of the  pancreatic ductal adenocarcinoma are  moderate to poorly 
differentiated.  
 
The major draw back is that immunohistochemical profile of pancreatic 
cancers and  hepatobiliary cancers  and some stomach cancers are 
similar. Hence  it is very difficult to conclude that the tumour’s primary 
site  is   pancreas . 
Mucinous tumors , which ranks second ,  next to adenocarcinoma  has  
slightly better prognosis. 
Incidence of pancreatic neuroendocrine tumors   is very  low .  
 
Role of cysteine cathepsins: 
 
Cysteine cathepsins ,  lysosomal proteases ,  that are often upregulated 
in various  cancers  . During cancer progression, cathepsins are  
translocated from the cytoplasm and  are secreted into the extracellular 
milieu, where they  causes proliferation , angiogenesis,  apoptosis and 
invasion  . 
These enzymes  promote tumor invasion through several  mechanisms: 
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• First, they  cleaves the basement membrane and the extracellular matrix 
components ,  which helps in the invasion  of tumor cells away from the 
primary tumor mass. 
•  Second,  cathepsins can cause  proteolysis by activating  other proteases 
such as matrix metalloproteinases and urokinase plasminogen activator, 
which in turn promote invasion. 
•  Finally,  cell adhesion protein, such as  E-cadherin, gets cleaved  at the 
cell surface, which causes disruption of  adherens junctions and thus 
facilitate cancer cell migration and invasion.[24] 
Classification of Cathepsins done according to their active site and 
functional status.That are used as  prognostic markers in cancer are  
Cathepsin D, cathepsin B and other cathepsins. Measurement  of  
Cathepsin D in pancreatic tissue is significant in predicting  disease free 
and overall survival. 
General belief is that elevated concentrations of cathepsin D in 
pancreatic cancer is highly significant indicators of the potential for 
recurrence. Cathepsin B, plays important role in pancreatic and 
colorectal because it causes rupture of  basement membrane , by causing  
degradation of laminin, . Cathepsin D in addition to proteolytic activity 
,also  has   mitogenic activity .  
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In a study by, the Methodist Hospital Research Institute, they studied  
proteolytic enzymes Cathepsin E  and Cathepsin D (Cath D) expression 
in malignancy. Cath E has a limited cellular localization and tissue 
distribution  , whereas Cath D  is present  ubiquitously . This results in  
less frequent association  of   Cath E with malignancy , when compared 
to cath D .  It is selectively expressed in certain  diseases such as 
pancreatic cancer. However, both  Cath E and Cath D have very similar 
substrate selectivity. Recently, Cath E expression was found to be 
extremely low in normal pancreas and foci of chronic pancreatitis ,  
upregulated highly  in early dysplastic cells and  in pancreatic cancer 
tissues.So they have shown that  Cath E could be an early marker for 
pancreatic cancer detection.[25]. 
 
Study by nakata et al , showed that ,Lysosomal enzymes, cathepsin B 
and D,plays vital role in their possible relationship to the ability of 
malignant cells to invade and metastasize. In our current investigation, 
cathepsin B and D  were detected immunohistochemically using avidin-
biotin-peroxidase complex method in the  21 patients  pancreatic cancer 
cells. Positive rate of detection of cathepsin B and D were found to be 
43% and 81%  respectively.In their study it  was found that  Cathepsin D 
stained more strongly than cathepsin B.The plasma membrane stained 
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intense strongly in both instances. They have found that  in pancreatic 
cancer cells , cathepsin B and cathepsin  D  expression doesn’t 
correlated with  the degree of metastasis to lymph nodes, liver, or lung 
.[26]. 
In a study by Mads Gronberg and Troels zakarias et al , they have done  
analysis  on proteins that were  up-regulated in pancreatic cancer such as 
cathepsin D, cathepsin B  , integrin β1 ,  macrophage colony stimulation 
factor and  fibronectin receptor . They  were also identified to be up-
regulated in their  proteomic study. After obtaining the Human Protein 
Reference Database they  provided a  list of  protein functions  and 
subcellular localization and annotations regarding presence of signal 
peptide . They listed information about  all proteins identified in the 
study such as  post-translational modifications,  and peptide sequences,  
heavy/light intensity ratios. Mac-2BP belongs to   scavenger receptor 
cysteine-rich domain family of proteins.  
Mac-2BP function is helps in binding  to galectins and fibronectin, 
collagen  and β1 integrins.  It has been  increased in serum of patients 
with different solid tumors, like  breast and pancreas , etc.It is associated 
with  metastatic spread in these malignancies  and resulting in  poor 
survival . In their  study, when  compared with normal cells ,  it was 
found to be  increased to 5-folds  in pancreatic cancer cells  . Cathepsin 
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B and cathepsin D were also detected in their  study. Cathepsins are 
nothing but  lysosomal proteolytic enzymes which is present in most of 
the mammalian cells. In different solid cancers ,  Cathepsins B and D , 
both are involved and were found to be  up-regulated 2- and 10-fold 
times, respectively. Up-regulation of  these proteins were also confirmed 
by Western blotting techniques.It was also found in their screening test  
that Prosaposin, a protein which is  interacting with cathepsin D. They 
are found to be  up-regulated upto 13 folds in pancreatic cancer   when 
compared with normal pancreatic tissue [27]. 
In a study by Wostbrock B, Sturm JW, Willeke F , They obtained 
samples from  seventy patients with pancreatic  ductal adenocarcinoma , 
with a 3 years period follow-up.  Cathepsin B and Cathepsin L 
expression was performed by immunohistochemical method using 
corresponding  polyclonal anti-Cathepsin B and Cathepsin L antibodies. 
By performing nonisotopic in situ hybridization method they  detected  
Cathepsin B and Cathepsin L expressing  cells . It was found that the 
immunoreactivity for cathepsin B  was 96% and  for Cathepsin L 90% .  
Cathepsin B and Cathepsin L expression were correlated  with  clinical  
parameters and pathological grading , and survival rate and results were  
tabulated . 
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They also detected cytoplasmic  localization of specific mRNA 
sequences. It was found that  tumor cells cytoplasm , fibroblasts and 
macrophages, expresses positive mRNA signals were obtained  in  77% 
of Cathepsin  B and 81% of Cathepsin L  respectively. Significant 
correlation  was found  between Cathepsin B and Cathepsin L 
expression and tumor grading (P < 0.05) by statistical analysis. 
Significant correlation (P = 0.05) was found between  Cathepsin B and 
lymphatic invasion in cancer cases. Survival  rate after curative surgical  
resection and expression of  Cathepsin B and Cathepsin L  was found to 
be statistically  significant by   Kaplan-Meier analyses (P < 0.05) . 
 Besides tumor size, and grading (P < 0.05) and  nodal status  and 
staging , in multivariate analysis  it was found that  both cathepsin B and 
L  are strong prognostic markers (P = 0.0001) . For recurrence  of 
pancreatic  cancer  after curative surgery , it was found in  a multivariate 
analysis  that  Cathepsin  B expression  can be used as single  prognostic 
marker and found to be statistically significant  (P = 0.0001). 
It was found that both Cathepsin B and Cathepsin L are strong and 
independent prognostic markers in resectable  adenocarcinoma rather 
than staging and tumor grading . Furthermore, it was found that  after  
surgical curative resection  Cathepsin B is a single prognostic marker  
for early recurrence.  
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Hence these data highlights  the role of  proteolytic enzymes in  invasion 
of tumor cells to adjacent sites  and to distant sites metastasis , so helps 
in  defining the  groups of patients  at risk for developing  recurrence 
and metastasis [28]. 
 
In a study by Ohta and Terada et al, they have analysed  in 23 pancreatic 
ductal adenocarcinomas surgically resected cases  immunohistochemical  
expression of  a  polyclonal antibody against cathepsin B and 
monoclonal antibody against Pancreatic trypsinogen. These proteolytic 
enzymes are invoved  extra cellular  matrix digestion .  In  invasive  
adenocarcinomas  pancreatic trypsinogen was expressed  in the  
carcinoma cells cytoplasm , in a coarse granular pattern in fifteen of 20 
(75%) cases   .  Lymph nodes metastasis also expressed pancreatic 
trypsinogen  .  Cathepsin B expression was found diffusely in the  
carcinoma cells cytoplasm in a fine granular pattern in 14 of 20 invasive 
adenocarcinomas (70%)  . Whereas , three  intraductal non-invasive  
adenocarcinomas did not express trypsinogen  as well as cathepsin B.  
Hence these findings suggests that pancreatic trypsinogen and cathepsin 
B expression occurs in  invasive  ductal adenocarcinomas but not in non 
invasive ductal carcinoma . In the process of pancreatic  carcinoma  
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progression , invasion and metastasis,   cathepsin B  and trypsinogen  
acts independently of each other.[29]  
          In a study by Hannah J.Whiteman et al , Overexpression of  
S100A6, and cathepsin D  was due to  increased expression of S 100 P  . 
Both  proteases ,  S 100 A 6 and cathepsin D  are associated with  
cellular invasion. Increase in cathepsin D expression causes  increased 
invasive potential of S100P.  
Conclusion of their study  data suggests that  poor  prognosis of  
pancreatic carcinoma was due to  the invasive and  metastatic potential 
created by these proteases [30]. 
 
In a study by  Mark E. Weeks, Sally E ,  Dowen et al  , they have found  
that increased expression of  S100P results in  significant changes in 
cathepsin D expression ,resulting in cytoskeletal changes. Identification 
of  Cathepsin D  on the gel in a row of four spots at  several pH units, 
which  indicates  post-translational modifications. In S100P-
overexpressing cell lines  three cathepsin D spots  seems  to present in 
abundance , which indicates post translational modification.  When there 
was no post-translational modifications , down regulation spot was 
identified. Cathepsin D believed to  exists in three forms:- unprocessed 
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pre pro cathepsin D, partially processed pro cathepsin D, and mature 
enzymatically active cathepsin D. Western blot analysis showed the 
active form of cathepsin D  showed mild  increased  expression  in 
S100P-overexpressing clones but  there is marked  increase in 
expression of  other two isoforms of cathepsin D   . The  invasive 
potential of cancer cells was believed to be due to  preproisoforms and 
proisoforms of cathepsin D . In S100P-over expressing cells  ,  they have 
carried out invasion assays mainly to look for  the cathepsin D 
contribution  to the invasive potential in these cells  . They have 
observed a significant increase in the invasion of S100P-overexpressing 
clones, with more than 2- 4 fold increase in the number of invading cells 
when  compared with controls. So to know the cathepsin D role in the 
invasive potential of S100P-overexpressing cells, they have examined its 
activity by  using a fluorogenic assay. There they have showed 
significantly higher cathepsin D activity in association with  S100P-
overexpressing cells when  compared with  control . Following 
treatment with 100 µmol/L of pepstatin A for 48 hrs, the cathepsin D 
inhibitor , activity of cathepsin D in S100P-overexpressing cells was 
decreased significantly to those  levels as observed in control cells. 
Hence they  repeated the cell invasion assays after  treating with 
pepstatin A. After inhibition of cathepsin D activity, they found a 
significant decrease in the number of invading , similar to that observed 
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for the control cell . They found that the increase in cathepsin D 
expression contributes to the  increased invasive potential of S100P-
overexpressing cells. They showed that S100P overexpression results in 
significant changes in the expression of  preproforms and proforms of 
cathepsin D with a milder increase in the active form. Since cathepsin D 
plays a critical role in extracellular matrix  proteolytic degradation , up 
regulation of  its expression is seen in several cancer types, including 
pancreatic ductal adenocarcinoma . The  procathepsin  D secretion and 
its conversion into enzymatically active cathepsin D , which has the 
propensity  to invade the cells , and hence associated with poor 
prognosis in pancreatic  cancer. They have observed increased 
expression  of both S100P and cathepsin D levels  in PaTu 8988s cells 
when compared with PaTu 8988t. These cells were isolated from the 
same  human primary pancreatic adenocarcinoma .  PaTu 8988s was 
isolated from poorly differentiated and highly  invasive and was 
associated with metastasis. PaTu 8988t cells are well differentiated and 
does not metastasize. Using a paired Student's t test ,statistical analysis 
of the data  revealed significance  P  value of < 0.05. 
Their  results suggests that the  increased cathepsin D expression has the 
ability to degrade the extra cellular matrix  resulting in  invasion and 
metastasis [31] 
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  In a study by Leto G et al, Lysosomal cathepsins B, L and D, they 
estimated the  serum levels  by immunoassays in patients with acute or 
chronic    pancreatitis and with ductal pancreatic carcinoma patients. 
Correlation has been done with clinical parameters and some biological 
parameters of the tumor. Expression of  Cathepsin B was found to be 
statistically  significantly (p < 0.01)  higher in pancreatitis and  ductal 
adeno carcionoma when compared with healthy subjects. But there is no  
difference between  these two  groups. .  Cathepsin D expression were 
increased in pancreatitis  patients when compared with cancer patients 
or  healthy subjects  (p < 0.01). Elevation of  Serum Cathepsin L levels 
were seen  in cancer patients only  when compared with pancreatitis and  
normal subjects (p < 0.05), but there is  no  difference  between  these 
two groups. In their study, no correlation was found between Cathepsin 
D,  B and L  levels and tumor size and  clinical stage. But, significant 
correlations were found between serum Cathepsin D and serum CA50  
levels and between Cathepsin D and Cathepsin L , which was found to 
be (p < 0.02)  and  (p < 0.05) respectively [32]. 
 
In a study by Brentnall TA,  Crispin DA, Goodlett DR,  Aebersold R et 
al  they used  tandem mass spectrometry and  ICAT technology -based 
proteomics to study systematically  in chronic pancreatitis ,the different 
37 
 
types  of protein expression  . They identified  116 differentially 
expressed proteins  in chronic pancreatitis  . Both  in pancreatic cancer  
and in chronic pancreatitis  40% of these proteins which were expressed  
differentially were detected in common  . This indicates that in between 
these two disease , some  proteins are expressed in common. Biological 
network  analysis indicates that  c-MYC is a common  regulatory protein 
,  involved in both   chronic pancreatitis and pancreatic carcinoma  . For 
validation by immunohistochemistry and  Western blot analysis , five 
proteins were chosen . Insulin-like growth factor-binding protein 2  and 
Annexin A2  were found to be  overexpressed in pancreatic cancer but 
not in chronic pancreatitis. Hence they can be used as promising 
biomarker detection of  pancreatic cancer. In  both pancreatic cancer and 
chronic pancreatitis ,  cathepsin D, were found to be overexpressed . In 
both these conditions it was also found that there was expression of  
integrin beta1, and plasminogen  .   These proteins were expressed in 
both conditions , hence   these proteins expression will lower the 
specificity  in pancreatic carcinoma .[33] 
 
In a study by Yamaguchi N, Chung SM et al, analysis in  pancreatic 
carcinoma cell line HPC-YP, spent culture medium ,  was done for the 
presence of the  secreted cysteine  protease, cathepsin L. The  lysosomal 
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form was distinguished  from secreted form of cathepsin L by its 
decreased stability at alkaline pH, by its reduced thermostability, and by 
its smaller molecular size.  HPC-YP cathepsin L was found to be  stable 
at 56 degrees C after 60-min preincubation, at  pH 7.4. Molecular weight 
of pancreatic cancer enzyme was found  to be 68,000, when  compared 
with a molecular weight of 29,000 for normal liver cathepsin L. HPC-
YP enzyme when analysed by western blot ,  was found to be composed 
of two components, one with a molecular weight of 31,000 and the other 
with a mol.wt  of 37,000.  HPC-YP enzyme in the spent medium 
analysis suggests that it is a complex of the proenzyme and the mature 
enzyme. In their study they have found that  cathepsin L  which is 
secreted from cancer cell lines  plays a  major role in the destruction of 
basal lamina, and helps in the  invasion of tissue, and  metastasis to 
distant sites.[34] 
In a study by Losch et al,they studied in 103 invasive ductal carcinomas 
of the breast , the immunohistochemical expression of cathepsin D , for 
the prognostic value  at stages pT1 and 2. They also analysed the 
cathepsin D expression and its association between histomorphological 
tumour subtypes, multifocal tumour and invasive ductal carcinoma with 
extensive intraductal component . Expression of cathepsin D was 
examined both within the epithelial and stromal component of all 
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tumours , separately  at two cut-off levels -positive and highly positive . 
Epithelial expression was detected in 20 (19.4%) as highly positive  and 
as positive in  32 (31.1%) patients . Stromal expression was found in 19 
(18.4 %) and  35 (34%)  cases.It was found that epithelial cathepsin D 
expression was associated with nuclear grade and  staging  , but not with 
lymph node status.  In their study , they have found statistically 
significant prognostic value for overall survival rate in highly positive ( 
p value = 0.003)  and  positive (p = 0.001)  cathepsin D expressing 
epithelial cells respectively and there was no tumor recurrence  , P value 
was  0.04 and 0.02. But  in stromal cells there was no associated with 
either recurrence  or survival rate  and expression of cathepsin D. Their 
study revealed the association of epithelial component of breast cancer 
cases survival rate and recurrence  and cathepsin D 
immunohistochemical  expression  . [35] 
             In a study by Shen et al,  they studied differentially expressed proteins 
in 7 cases of pancreatitis, and 6 normal pancreatic tissues, and in 6 cases 
of pancreatic carcinoma and  2  adjacent normal tissues by using mass 
spectrometry and  proteomic approach of two-dimensional  gel 
electrophoresis .  Extraction of protein of individual sample and pooled 
samples of each tissue type  were separated by using two different pH 
ranges , on 2D gels. After  gel digestion differentially expressed protein 
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spots were  identified by using mass spectrometry. In that they have 
found  overexpression of  peroxiredoxin I ,  cathepsin D, galectin-1, 
annexin A4, cyclophilin A,  alpha-enolase,  and S100A8   in pancreatic 
carcinoma  when compared with  normal pancreatic tissues and 
pancreatitis . These identified proteins were confirmed by 
immunohistochemical analysis  and western blot analysis.[36].  
 
In a study by Losch et al, they  investigated  the immunohistochemically 
detected cathepsin D expression and its  prognostic value  in endometrial 
adenocarcinoma. Patients included in the study were  Endometrial 
adenocarcinoma  cases of  all FIGO stages  and those who were 
receiving consecutive irradiation therapy. In 115 tissue specimens ,  they  
performed immunohistochemical expression of cathepsin D, out of 
which  35 cases were found to be positive . In the univariate analysis , 
they have showed statistically significant association  between 
expression of Cathepsin D and overall survival  rate (P-value = 0.007). 
In the multivariate analysis they found association between recurrence 
free period and  cathepsin D expression (P-value = 0.002 ).  Cathepsin D 
expression by immunohistochemical detection helps  in planning 
treatment for patients with  endometrial adenocarcinoma  and survival 
rate. [37]  
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In a recent  clinical  research discipline ,they have found that  peptic 
ulcer disease is one of the risk factor for the development of pancreatic 
cancer with the odds ratio of  3.9.  Intraductal papillary mucinous 
neoplasms  , a  pancreatic precursor lesion ,is  associated with 
development of  invasive pancreatic adenocarcinoma . Methylation of a 
gene promotor region causes altered gene expression resulting in 
inactivation of tumor suppressor gene.  In pancreatic adenocarcinoma  
more than 400 alterations in gene expression transcription have been 
identified. In situ neoplasia is associated with common molecular 
markers over expression such as p53 and HER-2/neu . Via  autocrine or  
paracrine mechanisms molecules such as epidermal growth factor ,TGF 
beta causes  modulation in gene transcription. Neoplastic cells  causes 
release of  several cytokines which causes cachexia , 
peripheral insulin resistance, ineffective utilization of glucose . In 
patients taking  chemotherapeutic regimens ,  Positron emission 
tomography scanning is used for evaluation of early tumor response   . 
Neoadjuvant 5-fluorouracil (5-FU) based chemoradiation  improved 
local tumor control  in 39  resectable  patients with  average survival rate 
of 19 months .  4-year  average survival rate in these cases was  19% . 
Gemcitabine has shown better clinical  response than single agent 5-
flurouracil  in alleviating tumor-related symptoms   (23.8 vs. 4.8%, p = 
0.0022.[38] 
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In a study by Bramhall SR, Allum WH,they studied treatment trends and 
outcome of 13,560  pancreatic cancer patients .The incidence of the 
pancreatic carcinoma were determined between 1957 and 1986 , using 
data  collected from the health registry , West Midlands . Patients were 
divided into two categories . Those diagnosed in the first 20 years 
(1957-76 ) and the next 10 years (1977- 86).  In their study they have 
found pancreatic adenocarcinoma were more common in men. When 
compared with bypass surgery  and laparotomy , the 30-day mortality 
rates between the two periods were improved after surgical resection . 
When compared with survival rate after bypass , there was  significant 
improvement in the 5-year survival rate after  resection (  P value was < 
0.015 ) .[39] 
By both direct and indirect mechanisms VEGF , a cytokine that 
accentuates  angiogenesis. VEGF stimulates nearby microvessels 
endothelial cells to proliferate,and to migrate  by causing  gene 
expression  pattern alteration and thereby causing these cells 
hyperpermeable which results in spillage of  plasma proteins into the 
extravascular space ,which further causes the clotting of extravasated 
fibrinogen resulting in deposition of a fibrin gel. Extravasated  fibrin 
functions  as a provisional matrix which  favors  the ingrowth of new 
blood vessels and other mesenchymal cells. TGF-alpha is a potent 
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angiogenic factor, but it does not by  itself causes  increase 
microvascular permeability.[40] 
 
             In a study by Wael Abd et al, they studied Cathepsin E  expression in 
pancreatic cancer . Cathepsin E activity was detected by using specific 
fluorogenic probes in   both   non-invasively image mouse xenografts 
from human pancreatic cancer cells (MPanc96) and in vitro.  Cath E 
selective peptide substrate, was synthesized and conjugated with a  
grafted copolymer to yield a fluorescently quenched probe. 
Fluorometerically  ,  probe specificity was identified in vitro. Near 
infrared  fluorescent imaging was performed before and after probe 
administration, in MPanc96 xenografts in nude mouse, at 18, 24, 48 and 
72 hrs respectively. For negative controls, control imaging probe were 
administrated into tumor-bearing nude mice. Using NIR fluorescence , 
ex vivo imaging was done for tissues of interest .  Native fluorescently 
quenched probe was converted to highly fluorescent state  upon specific 
Cath E cleavage  . Within 24 hr post-injection,  the probe  detected 
Mpanc96 tumors. High tumor ratio (~ 6) was observed when compared 
ro non tumor tissue  . There was no signal was derived from other tissues 
examined . The selectivity of the probe in detecting upregulation of  
Cathepsin  E in pancreatic cancer cells  was confirmed  [41] . 
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In a study by Gopinathan and Denicola et al, they have found that 
upregulation of  cathepsin B  in  ductal adenocarcinoma of  pancreas  . 
Hence this lysosomal protease  represents a potential therapeutic target . 
Cathepsin B loss causes decreased invasion and metastasis in mouse 
models of  intestinal ,  islet, and breast carcinoma , due to delay in 
tumour progression  . The aim of their  study was to know the role of 
cathepsin B in the  invasion and metastasis of human pancreatic ductal 
adenocarcinoma. The role of cathepsin B in vitro Cell lines derived from 
tumours were  investigated.  Using  subcutaneous allografts , role of 
cathepsin B in pancreatic adenocarcinoma were tested in both 
autonomous and non- autonomous cells .  The delayed progression of  
both pancreatic intraepithelial neoplasm  and  ductal carcinoma were 
due to constitutive cathepsin B loss and a improved  survival  in mice. 
Reduced  proliferation and  MAP signalling was due to Cathepsin B-loss 
in Pancreatic intraepithelial neoplasm  and  adenocarcinoma cells.[42]. 
 
 Study by Gukovskaya et al, they have done  study on alcohol 
consumption and risk of development of pancreatic cancer. It has been 
found  that there is some  interaction present between the pancreatic 
exocrine and endocrine parts  and also in inflammatory processes and 
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development of malignancy . Heavy alcohol consumption for long 
period results in the development of chronic pancreatitis and  type 2 
diabetes mellitus, both are risk factors for the development of pancreatic 
cancer. Alcohol and its metabolites will alter  the mechanisms involved 
in the development of inflammatory response and carcinogenesis. The 
following mechanisms are involved : (1)  activation of zymogens 
prematurely (2) activation of  nuclear factor-kappa which results in 
activation  of the inflammatory response  (3) oxidative DNA damage 
because of increased synthesis  of reactive oxygen species (4) fibrosis 
because of  pancreatic stellate cells activation  (5) gene mutation in 
enzymes related to cytochrome P450,  trypsinogen, and  secretory 
trypsin inhibitor , glutathione S-transferase, aldehyde dehydrogenase  
(6) additive  effects of carcinogen produced by ethanol and tobacco  on 
nitrosamine 4-1-butanone metabolism and (7) dysregulation of  cell 
division and (8)  apoptosis. Diabetes mellitus and acute and chronic 
pancreatitis develops as a result of interaction of  metabolic effects of 
alcohol with various risk factors such as  genetic, dietary, environmental  
and, ultimately, induces the steps involved in the  process of 
carcinogenesis which results in  the  pancreatic cancer development 
.[43]                
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In a study by William et al, they assessed the expression of  cathepsin E 
(Cath E)  enzymatic activity , which is strongly and specifically 
expressed in pancreatic intraepithelial neoplasia  lesions and  ductal 
adenocarcinoma.  By applying  immunohistochemistry and  quantitative 
real-time PCR method ,  cathepsin E expression  was analysed for 
normal pancreatic tissue, chronic pancreatitis and adenocarcinoma 
patients . Cathepsin E activity selective fluorescent probe was injected 
into human pancreatic adenocarcinoma xenografts and mouse models  of 
pancreatic adenocarcinoma which were  genetically engineered  and 
imaging was done using an optical imaging system. 
 By applying immunohistochemistry  and quantitative real-time PCR  ,  
Cath E expression specificity in adenocarcinoma  patients and in mouse 
model pancreatic cancer was confirmed. 
 It was also found that , by applying cathepsin E sensitive probe,  
detection of  pancreatic intraepithelial lesions in mouse model before 
tumour formation was also possible .[44] 
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WHO histological classification of exocrine pancreatic tumours 
Epithelial tumours 
Benign 
Serous cystadenoma  
Mucinous cystadenoma  
Intraductal papillary-mucinous  cystadenoma  
Borderline  
Mucinous cystic  neoplasm with moderate dysplasia . 
 Solid-pseudopapillary tumor 
Intraductal papillary-mucinous neoplasm with moderate dysplasia . 
Malignant 
Ductal adenocarcinoma  
• Noncystic mucinous carcinoma  
• Adenosquamous carcinoma  
• Signet ring cell carcinoma  
• Anaplastic carcinoma  
• Undifferentiated carcinoma with osteoclast-like giant cells 
• Acinar cell carcinoma  
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Mixed ductal-endocrine carcinoma  
Serous cystadenocarcinoma  
Mucinous cystadenocarcinoma – non-invasive and  invasive  
Intraductal papillary-mucinous carcinoma – non-invasive and invasive  
Acinar cell cystadenocarcinoma  
Solid-pseudopapillary carcinoma  
Mixed acinar-endocrine carcinoma  
Pancreatoblastoma  
Others 
Non-epithelial tumours 
Secondary tumours [23] 
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                                TNM CLASSIFICATION 
Primary tumor (T) 
TX Tumor cannot be assessed 
T0 No evidence of primary tumor 
Tis Carcinoma in situ 
T1 Tumor confined to the pancreas , measuring  less than 2 cm in 
diameter 
T2 Tumor confined to the pancreas, measuring more than  2 cm 
in  diameter 
T3 Tumor extension  beyond the pancreas ,  but there is no  
involvement of the  superior mesenteric artery or  celiac axis  
T4 Unresectable primary tumor. ie . tumor involving  the superior 
mesenteric artery or  the celiac axis  
Regional lymph nodes (N) 
NX Regional lymph nodes status cannot be assessed 
N0     No evidence of regional lymph node metastasis 
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             N1  Regional lymph node metastasis present. 
 
Distant metastasis (M) 
M0 No evidence of distant metastasis 
M1 Metastasis to distant sites present , ie. To the liver , lung ,etc 
 
            Tumor  staging  
Staging of the cancer is done by combining the T, N, and M 
classification. 
 
Stage 0: (Tis, N0, M0) -  indicates carcinoma in situ, in which the 
tumor has not yet extended outside the duct  in which it originated. 
 
Stage IA: (T1, N0, M0) -  tumor measuring less than  2 cm in the 
pancreas. Tumor  has not spread to distant sites  or regional  lymph 
nodes  . 
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Stage IB: (T2, N0, M0) -  tumor measuring larger than 2 cm  in the 
pancreas. Tumor has not spread to other parts of the body or regional  
lymph nodes. 
 
Stage IIA: (T3, N0, M0) -  tumor extending beyond the pancreas, but 
the tumor has not spread to other  body  parts  ,  arteries or veins or to 
the regional  lymph nodes . 
 
Stage IIB: (T1, T2, or T3; N1; M0) -  tumor of any size that  has 
spread to regional lymph nodes , but has not spread to nearby arteries 
or veins but not to other body parts . 
 
Stage III:  (T4, N1, M0) - tumor has spread to nearby regional  lymph 
nodes  or  arteries, veins, and/ but has not spread to other body  parts . 
 
Stage IV: (any T, any N, M1) -  Any tumor size that has spread to 
other body parts  such as liver , lung , brain , etc 
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  Surgical Classification 
This  method is more simpler and  found to be more descriptive than 
the American Joint Committee Cancer system . Here tumor 
classification done based on whether  the tumor can be surgically 
removed or not. 
 
Resectable: This tumor  type  can be removed surgically . These 
tumors  lies within the pancreas or extends to the adjacent  organs, but 
do not extend  into  local blood vessels. Tumor can be surgically  
resectable , only when  there is no evidence of  spread of the tumor  
outside the pancreas.  
 
Locally Advanced:  Using  traditional methods , these tumors cannot 
be removed surgically ,  because at the time of diagnosis tumor  has 
invaded nearby organs or  blood vessels . But, there is no evidence of 
spread to distant sites of the body.  
Metastatic: This  tumor type  cannot be removed surgically  because 
at the time of diagnosis  the tumor  has spread to other  body parts. 
Unfortunately,  most of the pancreatic tumor were detected at this  
unresectable stage .[45].  
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Treatment for pancreatic cancer depends on  its stage: 
 If pancreatic cancer is resectable, surgery followed by chemotherapy 
or radiotherapy improves survival rate. 
Resectable Pancreatic Cancer Treatment 
Patients with resectable  pancreatic cancer can  undergo any  of  the 
following surgeries- depending on the location : 
             1. Whipple pancreaticoduodenectomy :- removal of  parts of the 
stomach  and small intestine , and  the head of the pancreas, the 
gallbladder, and the common bile duct, and  some lymph nodes . 
             Rest of the  organs are connected for favour further digestion.  
  2 . Distal pancreatectomy : removal of  body and / or the tail of the             
pancreas , but not the head. This surgery is done for tumors located in                     
locations in pancreas without involvement of head. 
3 . Total pancreatectomy : Entire pancreas along with the spleen  is 
surgically removed completely. 
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Chemotherapy or radio therapy  
              Both can also be used in combination with surgery for both  
resectable and unresectable pancreatic cancer : 
• Neoadjuvant therapy  -given  before surgery ,  shrinks pancreatic 
tumor   thereby improving the chances of complete  resection. 
• Adjuvant therapy – given after surgery, delays  pancreatic tumor  
recurrence and thereby improves survival rate . 
 
             Chemotherapeutic  drugs used in  pancreatic cancer are the following : 
 5-fluorouracil (5-FU)  
 Gemcitabine 
In radiation therapy ,  beams of  high-energy X-rays were passed  to 
kill the tumor cells. Radiotherapy is given during a series of daily 
treatments, usually over a period of weeks. 
Treating Locally Advanced (Unresectable) Pancreatic Cancer 
 Treatment consists of nonsurgical therapies such as chemotherapy 
with or without radio therapy. For patients with locally advanced 
pancreatic tumor either  gemcitabine or 5 fluorouracil can  be used to 
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extend the life . 
Metastatic Pancreatic Cancer Treatment 
Here, surgery is done mainly to control  symptoms, such as for  
jaundice, or gastric outlet obstruction..  
Radiotherapy / chemotherapy-can also be used to relieve symptoms .  
Chemotherapy- Gemcitabine is the single most effective drug for 
treating metastatic pancreas cancer.  
Alternative - 4 drug regimen used , known as FOLFIRINOX ( 
combination of 5-FU/leucovorin/oxaliplatin/irinotecan), found to be  
superior to gemcitabine. Other combinations are: 
 gemcitabine with erlotinib, 
 gemcitabine with capecitabine 
 gemcitabine with cisplatin, 
 gemcitabine with nab-paclitaxel. . 
If an individual progresses on gemcitabine, usual regimens include 
oxaliplatin with 5-FU or capecitabine or cisplatin with 5-FU . 
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Palliative Treatment  
• Bile duct stents procedure -  relieves jaundice 
• Opiod analgesics - relieves pain. 
• Antidepressants – to treat depression                                                                                                                                          
Prognosis of  Pancreatic Cancer 
For all stages combined - 1-year relative survival rate is 25% 
                                          5-year survival is  less than 5%  to  6% 
For local disease, the 5-year survival is  20%.  
. In terms of months,  the median survival rate  for locally advanced and 
for metastatic disease,  is about 10 and 6 months respectively [17,18]. 
Without active treatment, metastatic pancreatic cancer has a median 
survival of 3–5 months.  
Complete remission is rare.  
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IMMUNOHISTOCHEMISTRY 
 Immunohistochemistry  plays role in both immunology and histology.     
Immunohistochemistry is used to determine the expression of particular 
antigen and its microanatomical location in the tissue.IHC uses antibody 
to distinguish the antigenic differences between the cells. These 
differences can specifically identify the lineage of cell population and 
define biologically the distinct population of cells within the same 
lineage. 
Immunohistochemistry was started in 1940,when coons developed an 
immunoflourescence technique to detect corresponding antigen in frozen 
sections. 
Taylor and colleagues in 1974 showed it was possible to demonstrate 
antigens in routinely processed tissues. Antigen retrival technique was 
introduced by shi and associates in 1991. antigen retrival technique is a 
simple method that involves heating paraffin processed sections at a 
high temperature before IHC staining. 
Enzyme digestion was introduced by Huang and colleagues as a 
pretreatment to immunohistochemistry staining to unmask some 
antigens that had been altered by formalin fixation . However  leong and 
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colleagues found that enzyme digestion did not improve the 
immunohistochemistry staining. 
 Another drawback of  enzyme digestion was that it is proved to be 
difficult to control the optional digestion condition for individual tissue  
when stained with different antibodies. These difficulties in 
standardization , provided a powerful incentive for the development of a 
new technique. 
The antigen retrival technique was developed by sln and his associates 
in 1991.In contrast to enzyme digestion this technique is a simple 
method that involves heating routinely processed paraffin sections at 
high temperatures before  the immunohistochemistry staining. An 
alternative method that did not use heating was applied in celloidin 
sections.  
Various articles demonstrated that the immunohistochemistry staining 
intensity was dramatically increased after antigen retrieval pretreatment. 
 One of the critical issues in the development of immuno peroxidase  
techniques was related to the need to achieve greater sensitivity from  
the  one step direct conjugate method to multi step  techniques such as 
the peroxidase and anti peroxidase method , avidin biotin conjugate and  
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biotin sterptavidin method , together with amplification methods and 
highly sensitive polymer based labeling techniques. 
The development of hybridoma techniques facilitated the improvement 
of immunohistochemistry and results in the production of highly specific 
monoclonal antibodies. Many of these antibodies were initially applied 
in staining of  tissues , later they have found to be applied successfully  
in formalin fixed paraffin embedded tissue sections. 
The use of antibody in IHC depends on the sensitivity and specificity of 
the antigen and antibody reaction and the hybridoma technique provides 
limitless source of  highly specific antibody. 
 
Basic Principles  
          The object of all stains is to recognize the existence and 
distribution of substances  micro chemically . 
Basic principle applied here is that  sharp localization of target 
compounds in cells and tissues , based on signal to noise ratio. The 
major strategy to achieve a satisfactory result is by amplifying signals 
that reduces non specific background staining ( noise). 
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An antibody is a molecule that combines specifically with the antigen. 
Antigen – antibody recognition is based on revealing  protein structure , 
in which antigen retrieval plays crucial role. 
Comparison of sensitivity and specificity  between polyclonal and 
monoclonal antibodies indicate that  polyclonal antibodies are more 
sensitive but less specific than monoclonal antibody . The reason is that 
polyclonal antibody recognize several epitopes on a single antigen , 
whereas monoclonal antibody recognizes only particular type of epitope 
on a single antigen. 
Fixative used – 10 % Neutral Buffered Formalin 
 Antigen Retrieval 
 The disadvantage of masking of antigens during fixation can be 
overcome by antigen retrieval technique . Techniques used to unmask 
the antigens are the following : 
• Proteolytic enzyme digestion  
• Microwave antigen retrieval 
• Pressure cooker antigen retrieval 
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Blocking non-specific background staining 
Background staining is due to either non specific binding or the presence 
of endogenous enzymes. Non specific binding with polyclonal primary 
antibody is minimized by preincubating sections with serum from same 
species on optimal working dilution. 
Endogenous enzymes such as peroxidase seen in normal and neoplastic 
tissues are abolished by peroxidase blocking or by using alternate 
system such as Immunogold technique. 
Methods suggested to overcome endogenous activity include incubation 
in methanol containing 0.5% hydrogen peroxide for 10 minutes at room 
temperature  . By addition 0.1M concentration of levamisole solution to 
the enzyme substrate solution , endogenous alkaline phosphatase is 
blocked . 
Detection system  
Antibodies are labeled or flagged by some method to permit 
visualization- these include fluorescent substances, enzyme forming 
colored reaction with suitable substrate(light microscopy) or heavy 
metals (electron microscopy). 
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Methods of IHC 
Direct labeling method 
Antibody is attached with a label by chemical means and directly 
applied to tissue sections. It is rapid and easy procedure and carries the 
disadvantage of multiple antigens which requires separate incubation 
with respective antibodies. 
 
Indirect labeling technique 
Enzymes are labeled with the secondary antibody, which is produced 
against primary antibody. This method is more sensitive and easy to 
handle. The advantages also include increased versality, higher working 
dilution of primary antibody, secondary antibodies against primary 
antibodies of different species and easy to prepare. 
 
Avidin biotin techniques 
 High affinity binding between biotin and avidin is used in this 
procedure. Biotin is chemically linked to primary antibody thus 
localizing the peroxidase moiety at the site of antigen. 
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Disadvantage of this technique is that the endogenous biotin produces 
non  specific background staining. 
 
Avidin biotin conjugate procedure 
In this technique primary antibody is added followed by biotinylated 
secondary antibody and next by preformed complexed of avidin and 
biotin horse radish peroxidase conjugate.This is a more sensitive 
method. 
 
Biotin streptavidin system 
Streptavidin is used in place of avidin. Streptavidin is more stable than 
avidin. 
Immunogold silver staining technique 
This is used in ultrastructural immunolocalisation. Gold particles are 
enhanced by the addition of several layers of metallic silver. The fine 
silver deposits in the background creates confusion when small amount 
of antigen are identified. 
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                         MATERIALS & METHODS 
This study was done after obtaining the approval from Institutional 
Human Ethical Committee (IHEC) of Govt. Stanley Medical College, 
Chennai. 
The study was carried out in the Department of Pathology, Govt.Stanley 
medical college, in collaboration with the Department of Surgical 
Gastroenterology,  
from February 2010 to August 2012. 
Total of 50 whipples pancreato duodenectomy specimens were taken for 
this study. 
Eligibility Criteria: 
Inclusion Criteria- 
All specimens of pancreatic cancer by pancreatectomy and whipple’s 
pancreatico duodenectomy were processed routinely and stained with 
hematoxylin and eosin.  
Exclusion Criteria- 
Biopsy proven cases of benign pancreatic lesions, cysts, carcinoma in 
situ cases  
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METHOD: 
For all the 50 cases,details of age,sex and other relevant clinical data 
were recorded. 
Site of growth,size,gross appearance and three dimensional 
measurement taken. 
Multiple bits from the growth and the adjacent areas were taken and 
processed routinely for paraffin embedding and sections were cut at 5 
microns. 
Hematoxylin and eosin staining of sections were done.Histopathological 
examination of these sections were done. 
Necessary photographs were taken. 
Sections from pancreatic carcinoma are graded according to their degree 
of differentiation into well,moderate and poorly differentiated.Perineural 
invasion and lymphovascular invasion were noted. 
Immunohistochemical study using cathepsin D antibody was done in 50 
cases and degree of antibody expression was scored in each case. 
 
Method applied for tissue preparation of IHC 
          10 % buffered neutral formalin were used for specimen fixation. 
The tissues were processed in automated histokinette through various 
grades of alcohol and xylene . Paraffin blocks were prepared . Sections 
were cut using semi automated microtome with disposable blade and 
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stained with hematoxylin and eosin . Suitable sections were chosen for 
IHC .  
           Slides were coated with chrome alum . Sections were subjected to 
antigen retrieval using microwave technique with TRIS –EDTA  buffer 
solution.  
 
 PROCEDURE  
1.Deparaffinise sections using xylene – 2 changes –each 15 minutes and 
90% alcohol -1 min and 70 % alcohol -1 minute  
2. Running tap water wash -10 minutes 
3. Rinse in distilled water – 2 minutes 
4. Antigen retrieval by microwave method in citrate buffer – 15 minutes  
5. Cool to room temperature for 10 -20 minutes 
6. Rinse in distilled water – 5 minutes 
7. Rinse in TBS buffer – 2 changes – each 5 minutes 
8. Peroxidase block -15 minutes 
9.  Rinse in TBS buffer – 2 changes – each 5 minutes 
10. Power block -15 minutes 
11. Drain and cover with primary antibody -1 hour 
12.  Rinse in TBS buffer – 2 changes – each 5 minutes 
13. Super enhancer- 30 minutes 
14.  Rinse in TBS buffer – 2 changes – each 5 minutes 
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15. Secondary antibody label with horse raddish peroxidase- 30 minutes 
16. Rinse in TBS buffer – 2 changes – each 5 minutes 
17. DAB and substrate solution – 5- 10  minutes 
18. Wash in distilled water- 5 minutes 
19. Counterstain with hematoxylin – 1 minute 
20. Air dry and mount in xylene 
 
  Evaluation of Immunostaining: 
Cathepsin D expression  was  scored by counting the number   of all 
positive cells per x 100 field, which includes carcinoma cells and 
stromal cells such as fibroblast,  and lymphocytes. 
Tumor cells were compared in all samples. 
 
SCORING OF CATHEPSIN D EXPRESSION: 
0 - no staining . 
1- If the tumor tissue consists of  less  than 10% immunoreactive cells 
2 - 10–50% immunoreactive cells 
3-  more than 50% immunoreactive cells 
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                                RESULTS AND OBSERVATION 
The collected details of cases have been recorded in the master chart. All 
collected data were analyzed and following results were obtained 
    Table-1:Age distribution of pancreatic carcinoma 
Age(yrs) No. of 
patients 
% of cases 
30-40 1 2 
40-50 19 38 
50-60 22 44 
>60 8 16 
Total number of patients included in this study was 50.Age group ranges 
from 30-70 years, with mean age of 53 years.Pancreatic carcinoma 
peaks in the age group of 50-60 years. 
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      Table-2: Sex distribution of pancreatic carcinoma 
Sex No. of patients % of cases 
Male 34 68 
Female 16 32 
 
Out of 50 cases of pancreatic adenocarcinoma , males  were 34  ( 68%)  
and  females were 16 (32 %) with a M : F  of  2.1:1. 
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    Table-3: Size of the tumor 
Size No. of 
cases 
% of cases 
<2 cm 18  36 
>2cm 32 64 
 
Out of 50 cases of pancreatic adenocarcinoma , 18(36%) were less than 
2 cm and 32(64%) were more than 2 cm. 
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     Table-4: Tumor grading 
Grade No. of 
cases 
% of 
cases 
WD   6 12 
MD 21 42 
PD 23 46 
 
Out of 50 cases of pancreatic adenocarcinoma,6(12%) cases were well 
differentiated,21(42%) were moderately differentiated and 23(46%) 
cases were poorly differentiated carcinoma. 
In our study,  most of the cases were moderately to  poorly 
differentiated. 
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              Table-5: Site of growth 
Site of tumor No.of cases      % of cases 
Head    41 82 
Body and tail      9 18 
 
Out of 50 cases of pancreatic carcinoma,41(82%) were located in head 
of the pancreas and 9(18%) were located in body and tail of pancreas. 
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 Table-6:Risk factors such as smoking, alcohol intake in 50 patients   
of pancreatic carcinoma 
                                          
Risk 
factor 
Males Females % of 
cases 
Alcohol 25     -    80.6 
Smoking 20     -    64.5 
 
Out of 50 cases,25 (80.6%) were alcoholic and 20 (64.5%) were 
smokers. 
Risk factors
alcohol
smoking
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Table-7: Association between alcoholism and pancreatic carcinoma 
in male cases - Chi square test 
 
Out of 50 cases of Pancreatic adenocarcinoma,25 (80.6%) were 
alcoholic. out of 25 alcoholics 19(76%) were associated with pancreatic 
adenocarcinoma.                                      
By applying chi square test using  SPS software version 16.0 ,  p value is 
found to be  0.035 which is significant 
 
 
Alcoholism 
  Pancreatic 
carcinoma 
 
    
Total                         present absent 
present 19 6 25 
absent 2 7 9 
Total 21 13 34 
75 
 
 
 Table-8:Association between smoking and pancreatic carcinoma in 
male cases - Chi square test 
 
Smoking Pancreatic carcinoma         Total 
 present absent  
present 16 4 20 
absent 3 8 11 
Total 19 12 31 
 
 
Out of 50 cases of pancreatic adenocarcinoma,20 (64.5%) cases were 
smokers.Out of 20 smokers,16 (80%) cases were associated with 
pancreatic adeno carcinoma. 
By applying chi square test using  SPS software version 16.0 ,  p value 
was 0.035 , which is significant. 
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              Table-9:  Pancreatic carcinoma cases associated with pancreatitis 
 
H/o 
pancreatitis 
No.of 
patients 
% of 
cases 
Present 34 68 
Absent 16 32 
 
Out of 50 cases of pancreatic adenocarcinoma, 34 (68%) were 
associated with previous history of pancreatitis,and  in 16 (32%) of 
cases there was no previous history of pancreatitis. 
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                 Table-10:Lymph node metastasis 
Lymph 
node mets 
No. 
of 
cases 
% of 
cases 
Present       
35 
     
70 
absent       
15 
     
30 
 
Out of 50 cases of pancreatic adenocarcinoma, lymph node metastasis 
were present in 35 (70%) of cases and absent in 15 (30%) of cases. 
                Table- 11:Perineural invasion 
Perineural 
invasion 
No.of 
cases 
% of 
cases 
Present 28     56 
Absent 22     44 
 
Out of 50 cases of pancreatic adenocarcinoma, Perineural invasion were 
present in 28 (56%) of cases and absent in 22 (44%) of  cases. 
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 Table-12:Pancreatic carcinoma association with LFT 
 
                 LFT No.of cases % of cases 
Increased        36  72 
Normal        14 28 
 
Out of 50 cases of pancreatic adenocarcinoma,LFT is increased in 36 
(72%) of cases and normal in 14 (28%)  of cases. 
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          Table-14 :  Association between perineural invasion and LN mets in       
all cases - Chi square test 
 
LN 
mets 
 
      Perineural invasion    
Total present absent 
present 25 5     30 
absent 5 15     20 
Total 30 20     50 
 
 
Association between perineural invasion and lymph node metastasis was  
done by applying chi square test. 
By applying chi square test using  SPS software version 16.0 , p value  
was found to be 0.000 ,  which is highly significant. 
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              Table-15:Tumor grading based on HPE and cathepsin expression 
Grading  No.of 
cases in 
HPE  
No.of cases 
 expressing 
cathepsin D 
    1  6  4  
    2  21  22  
    3  23  24  
 
Tumor grading based on Histopathological examination  and cathepsin 
D expression was done .Out of  50 cases of  pancreatic adenocarcinoma , 
6 cases were  well differentiated pancreatic adenocarcinoma , cathepsin 
D expression score of 1 was given for 4 cases.   21 cases were 
moderately differentiated adenocarcinoma . cathepsin D expression 
score of  2 was given for 22 cases. . 23  cases were poorly differentiated 
pancreatic adenocarcinoma. cathepsin D expression score of 3 was given 
for 24 cases. 
 Our study shows that increased expression of cathepsin D  was 
associated with increased grading of  pancreatic adeno carcinoma . 
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 Table 16: 
Association between cathepsin expression grading with Serum 
Carbohydrate antigen  19.9 levels in all cases: 
 
Sr CA 19.9 LEVELS GRADE 1 GRADE2 GRADE 3 
>50 1 3 22 
35 -50 1 18 2 
<35 2 1 - 
TOTAL 4 22 24 
 
By applying  SPS software version 16.0 ,  One way ANOVA test for 
cathepsin D expression and Serum carbohydrate 19.9 levels done. 
It showed significant increase in Carbohydrate antigen 19.9 levels in 
association with cathepsin D expression progression. 
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                                    DISCUSSION 
This retrospective study was carried out in the Department of Pathology, 
Govt. Stanley medical college, in collaboration with the Department of 
Surgical Gastroenterology.Total of 50 whipples pancreatoduodenectomy 
specimens were taken for this study and were evaluated. 
 In our study pancreatic adenocarcinoma was most common in 40 to 60 
years. 
Males were more frequently affected than females. Most of the cases 
were moderately to poorly differentiated , associated with perineural 
invasion and lymphatic invasion. Serum carbohydrate antigen  19.9 level 
was found to be elevated in association with moderate to poorly 
differentiated carcinoma. 
            Histological grade and stage influences the prognosis of pancreatic 
adenocarcinoma. Well differentiated adenocarcinoma and those 
measuring less than 2 cm , without lymphatic and perineural invasion 
were associated with better  survival, whereas poorly differentiated 
adenocarcinoma and locally advanced carcinoma and those associated 
with perineural invasion and lymphatic invasion had poor  survival rate. 
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The main aim of this study is to know the association between  
pancreatic adeno carcinoma grading and expression of cathepsin D  and 
its relationship with perineural and lymphatic invasion and its impact on 
survival rate .Secondary objective is to know the association of 
pancreatic adenocarcinoma grading with biochemical parameters such as 
serum carbohydrate antigen 19.9 levels and liver function test. 
In our study, moderate to poorly differentiated pancreatic 
adenocarcinoma shows increased intensity of expression of cathepsin D 
as well as increased number of pancreatic cancer cells showing 
positivity when compared with well differentiated adenocarcinoma . 
This is correlating with the study done by Wost brock B and Strum JW 
where they have found that significant statistical correlation between 
pancreatic adeno carcinoma grading and expression of cathepsin B and  
cathepsin D.  
       Pancreatic carcinoma peaks in the age group of 50-60 years , with mean 
age of 53 years in our study.It is rare below 40 years and above 70 years. 
This is correlating with the study done by Ohta and Terada where they 
have shown that pancreatic adeno carcinoma peaks in the age group of 
40 to 60 years. 
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             The male to female ratio of pancreatic adenocarcinoma in our 
study is 
 2.1 :1. Losch et al says that in their study male to female ratio was 1.8:1 
with male  preponderance. 
Most of the cases ( 64%) in our study were measuring more  than 2 cm . 
Most of these cases were located in the head of the pancreas. This is 
correlating with the study done by Yamaguchi N and Chung SM et al. 
 
Those cases that are located in the head of the pancreas presented in 
advanced stage extending into adjacent organs and they are associated 
with lymphatic and perineural invasion.This is similar to the study done 
by Hannah J Whiteman and Sally E. Doewn et al where they have found 
that cases that are located in the head of the pancreas presented in 
advanced stage and have increased probability of lymphatic and 
perineural invasion. 
 
In our study Out of 50 cases of Pancreatic adenocarcinoma , 25 (80.6%) 
were alcoholic. out of 25 alcoholics 19(76%) were associated with 
pancreatic adenocarcinoma and the p value was found to be  0.035 
which is significant. 
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            Out of 50 cases of pancreatic adenocarcinoma,20 (64.5%) cases were 
smokers. Out of 20 smokers,16 (80%) cases were associated with 
pancreatic adeno carcinoma. p value was found to be 0.035 which is 
significant. 
            Out of 50 cases of pancreatic adenocarcinoma, lymph node metastasis 
were present in 35 (70%) of cases and absent in 15 (30%) of cases. 
Perineural invasion were present in 28 (56%) of cases and absent in 22 
(44%) of  cases. Lymph node  metastasis and perineural invasion were 
seen especially in cases of moderately to poorly differentiated adeno 
carcinoma in high percentage when  compared with well differentiated 
adeno carcinoma. By applying chi square test for its correlation with 
pancreatic adenocarcinoma  p value was found to be 0.000 which is 
highly significant. This finding  is correlating with the study done by 
Niedegethmann M and Willeke and Hildenbrand et al .In their study 
they have observed that perineural and lymphatic invasion were 
associated with increased grading of pancreatic adeno carcinoma. 
             Out of 50 cases of pancreatic adenocarcinoma,LFT is increased in 36 
(72%) of cases and normal in 14 (28%)  of cases serum Carbohydrate 
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antigen 19.9 level is increased above 37 U/ml  in 42(84%) of cases and 
less than 37U/ml in 8(16%) of cases. 
 
Tumor grading based on Histopathological examination  and cathepsin 
D expression was done in our study. Out of  50 cases of  pancreatic 
adenocarcinoma 6 cases were  well differentiated pancreatic 
adenocarcinoma , cathepsin D expression score of 1 was given for 4 
cases.   21 cases were moderately differentiated adenocarcinoma . 
Cathepsin D expression score of  2 was given for 22 cases. . 23  cases 
were poorly differentiated pancreatic adenocarcinoma. cathepsin D 
expression score of 3 was given for 24 cases. Our study shows that 
increased expression of cathepsin D  was associated with increased 
grading of  pancreatic adenocarcinoma. This finding  is similar to  study 
done by Ohta and Terada et al,where they have found that cathepsin 
expression is increased with increased grade of  pancreatic adeno 
carcinoma. 
 One way ANOVA test for cathepsin D expression and Sr. carbohydrate 
antigen 19.9 levels done . It showed significant increase in CA 19.9 
levels in association with cathepsin  D expression progression. 
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                                        SUMMARY & CONCLUSION 
 
Out of the 50 whipples specimen studied, we found that pancreatic 
adenocarcinoma was most common in the age group of  40 to 60 years. 
Of which males were more frequently affected than females with a male 
to female preponderance ratio of 2.1 :1. Most of the cases were 
moderately to poorly differentiated  carcinoma, associated with 
perineural invasion and lymphatic invasion. Serum CA 19.9 level was 
found to be elevated in association with moderate to poorly 
differentiated carcinoma. 
 
In our study, moderate to poorly differentiated pancreatic 
adenocarcinoma showed increased intensity of expression of cathepsin 
D as well as increased number of pancreatic cancer cells showing 
positivity when compared with well differentiated adenocarcinoma . 
Most of the tumour size ( 64%) in our study measured more  than 2 cm. 
They were mostly located in the head of the pancreas and presented in 
advanced  stage extending into adjacent organs and were associated with 
lymphatic and perineural invasion. 
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          In our study, out of the 50 cases of pancreatic adenocarcinoma, 25 
(80.6%) were alcoholic and there was a significant association between 
pancreatic adeno carcinoma and alcoholics with a p value of  0.035. 
20 (64.5%) cases were smokers and 16 (80%) cases were associated 
with pancreatic adeno carcinoma. The association between both these 
variables showed a p value of  0.035 which was significant. 
 
Lymph node metastasis were present in 35 (70%) of cases and 
perineural invasion were present in 28 (56%) of cases and absent in 22 
(44%) of  cases. Perineural invasion and lymph node metastasis were 
especially seen in cases of moderately to poorly differentiated 
adenocarcinoma in high percentage when being compared with well 
differentiated adenocarcinoma.  By applying chi square test for its 
correlation with pancreatic adenocarcinoma,  p value was found to be 
0.000 which was highly significant. 
 
LFT was increased in 36 (72%) of cases and serum CA 19.9 level was 
increased above 37 U/ml  in 42(84%) of cases. 
 
One way ANOVA test for cathepsin D expression and Sr. CA 
19.9 levels was done and it showed significant increase in CA 19.9 
levels in association with cathepsin  D expression progression. 
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Tumor grading based on histopathological examination  and 
cathepsin expression were done in our study. Out of the 50 cases of  
pancreatic adeno carcinoma 6 cases were  well differentiated adeno 
carcinoma of which the cathepsin D expression score of 1 was given for 
4 cases. 21 cases were moderately differentiated, of which cathepsin D 
expression score of  2 was given for 22 cases. 23  cases were poorly 
differentiated, of which cathepsin D expression score of  3 was given for 
24 cases.  
 
Hence our study showed that increased expression of cathepsin D 
was associated with increased grading of  pancreatic adeno carcinoma , 
results in poor survival. 
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GROSS – Whipples pancreatoduodenectomy showing pancreatic growth 
 
 
GROSS – Whipples specimen with pancreatic growth and peripancreatic 
lymphnodes 
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10 X view- Welldifferentiated  pancreatic adenocarcinoma 
 
10 X VIEW – Moderately differentiated adenocarcinoma 
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               10 x VIEW –Poorly differentiated adenocarcinoma 
 
45 X VIEW – showing perineural invasion 
 
93 
 
 
10 X  VIEW – Cathepsin D Expression  Score 1 
 
                               10 X VIEW – Cathepsin D Expression –Score 2 
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   10 X VIEW –Cathepsin D Expression –Score3 
 
      10 X VIEW- Perineural Invasion expressing cathepsin D 
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